{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:34:32Z","timestamp":1780353272841,"version":"3.54.1"},"reference-count":61,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"Paratek Pharmaceuticals"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2022,6,29]]},"abstract":"<jats:p>\n            Treatment of infections due to\n            <jats:named-content content-type=\"genus-species\">Acinetobacter baumannii<\/jats:named-content>\n            often involves the use of multiple antibiotics simultaneously as combination therapy, but it is unknown which antibiotics are best used together. Tetracycline agents such as minocycline and tigecycline maintain good activity against\n            <jats:named-content content-type=\"genus-species\">A. baumannii<\/jats:named-content>\n            and are often used with one or more other agents to achieve better killing of the bacteria.\n          <\/jats:p>","DOI":"10.1128\/spectrum.00542-22","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T13:00:16Z","timestamp":1654088416000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":16,"title":["Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility"],"prefix":"10.1128","volume":"10","author":[{"given":"Taylor","family":"Abbey","sequence":"first","affiliation":[{"name":"College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alesia","family":"Vialichka","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Jurkovic","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Biagi","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Illinois Chicago, Rockford, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3914-8400","authenticated-orcid":true,"given":"Eric","family":"Wenzler","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","unstructured":"World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research discovery and development of new antibiotics. 2017. https:\/\/www.who.int\/medicines\/publications\/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf. Accessed November 14 2021."},{"key":"e_1_3_3_3_2","unstructured":"U.S. Department of Health and Human Services Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States 2019. 2019. https:\/\/www.cdc.gov\/drugresistance\/pdf\/threats-report\/2019-ar-threats-report-508.pdf. Accessed November 14 2021."},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-019-0706-5"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01154-19"},{"key":"e_1_3_3_6_2","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"CLSI","year":"2021","unstructured":"CLSI. 2021. Performance standards for antimicrobial susceptibility testing, M100-S31 ed. Clinical and Laboratory Standards Insitute, Wayne, PA.","edition":"100"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz827"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy378"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab1013"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.02.016"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0267-8"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy293"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx176"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01066-13"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-019-00843-4"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2446"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30796-9"},{"key":"e_1_3_3_18_2","unstructured":"Kaye K Marchaim D Thamlikkikul V Carmeli Y Chiu CH Daikos G Dhar S Durante-Mangoni E Gikas A Kotanidou A Paul M Roilides E Rybak M Samarkos M Sims M Tancheva D Tsiodros S Devine G Ghazyaran V Pogue J. 2021. Results from the OVERCOME trial: colistin monotherapy versus combination therapy for the treatment of pneumonia or bloodstream infection due to extensively drug-resistant Gram-negative bacilli abstr 4773. Abstr 31st ECCMID 9 to 12 July 2021. European Society of Clinical Microbiology and Infectious Diseases."},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30099-9"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01230-13"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.01.015"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02166-13"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv086"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw590"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa778"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01823-12"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.12.009"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.04.006"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01176-17"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa508"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01680-20"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01624-13"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.01.017"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2016.06.006"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04110-14"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7060159"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-017-0153-2"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2021.08.012"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2019.02.017"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02262-18"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt197"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2020.08.021"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53714-0"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1159\/000356755"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2017.12.023"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02307-18"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2009.99"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0737-6"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01415-17"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks261"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw1004"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/42.6.793"},{"key":"e_1_3_3_53_2","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"CLSI","year":"2020","unstructured":"CLSI. 2020. Performance standards for antimicrobial susceptibility testing, 30th ed. Document M100-S30. Clinical and Laboratory Standards Insitute, Wayne, PA.","edition":"30"},{"key":"e_1_3_3_54_2","volume-title":"Methods for determining bactericidal activity of antimicrobial agents","author":"CLSI","year":"1999","unstructured":"CLSI. 1999. Methods for determining bactericidal activity of antimicrobial agents, M26-A ed. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"26"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01032-15"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02228-17"},{"key":"e_1_3_3_57_2","doi-asserted-by":"crossref","unstructured":"Cornely OA Arenz D Barraud O Bayliss M Dimitriou V Lovering AM Alasdair Macgowan A Cammarata SK Fusaro K Griffith DC Morgan EE Loutit JS. 2018. Phase I study to evaluate the safety and pharmacokinetics of single and multiple ascending doses of intravenous minocycline in healthy adult subjects poster #P1387. The IDWeek Annual Meeting 2018 San Fransico CA.","DOI":"10.1093\/ofid\/ofy210.1218"},{"key":"e_1_3_3_58_2","unstructured":"Minocin (minocycline) [package insert]. 2015. The Medicines Company Parsippany NJ. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/050444s049lbl.pdf. Revised April 2015. Accessed November 14 2021."},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit334"},{"key":"e_1_3_3_60_2","unstructured":"Rifadin (rifampin) [package insert]. 2019. Sanofi-Aventis Bridgewater NJ. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/050420s080 050627s023lbl.pdf. Revised February 2019. Accessed November 14 2021."},{"key":"e_1_3_3_61_2","unstructured":"Unasyn (ampicillin\/sulbactam) [package insert]. 2008. Pfizer Inc. New York NY. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/050608s029lbl.pde. Revised April 2007. Accessed November 14 2021."},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1086\/431674"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00542-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00542-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T13:50:26Z","timestamp":1656510626000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.00542-22"}},"subtitle":[],"editor":[{"given":"Bonnie Chase","family":"Prokesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6,29]]}},"alternative-id":["10.1128\/spectrum.00542-22"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.00542-22","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"2022-03-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00542-22"}}